SKYSONA: payments to doctors
Payments that named SKYSONA as the associated drug or biological, reported under the Sunshine Act for program years 2019–2025.
- Total reported
- $366K
- Providers
- 46
- Transactions
- 104
- Average per transaction
- $3,522
The per-transaction average — $3,522 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 46 providers the average total is $7,963, but that average hides a very steep distribution.
Companies reporting these payments
| Company | Total reported | Share |
|---|---|---|
| Bluebird Bio, Inc. | $345,932 | 94.4% |
| Genetix Biotherapeutics Inc | $20,380 | 5.6% |